Lexpos News

MHRA Class 2 Medicines Recall: Fucidin 250 mg Tablets, LEO Laboratories Ltd trading as LEO Pharma Drug alert number: EL(25)A/38 Date issued: 04 August 2025 LEO Pharma is recalling the affected batch as a precautionary measure due to out of specification results for impurities during routine stability testing. DMRC reference number: DMRC-36306427 Company name: LEO [...]

The post MHRA Class 2 Medicines Recall: Fucidin 250 mg Tablets, LEO Laboratories Ltd trading as LEO Pharma appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 August 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Hydrocortisone 500microgram granules in capsules for opening Alkindi® 0.5 mg granules in capsules [...]

The post 10 products re-classified as special containers from August 2025 appeared first on Community Pharmacy England.

Registration for the new Children’s Flu Vaccination Service for children aged 2-3 years is now open on the NHS Business Services Authority’s Manage Your Service (MYS) portal. As announced last week, this is one-season trial of the new Advanced service and pharmacy owners that choose to provide the service will be able to commence vaccinating eligible [...]

The post Children’s Flu Vac: Registration has now opened appeared first on Community Pharmacy England.

Changes are being made to the Manage Your Service (MYS) pharmacy portal, aimed at improving user experience. The new-look portal will be launched on Thursday 21 August 2025. Please note: the MYS portal will be temporarily unavailable between 7:00am to 8:30am on Thursday 21 August 2025 whilst NHS Business Services Authority (NHSBSA) make the changes. What’s [...]

The post Upcoming changes to the MYS Portal appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Olmesartan medoxomil 10mg film-coated tablets (Jubilant Pharmaceuticals NV) Date issued: 31 July 2025 Drug Alert Number: EL(25)A/37 Jubilant Pharmaceuticals NV has informed the MHRA that the Patient Information leaflet (PIL) in the cartons for the batches listed in this notification include an outdated PIL. DMRC reference number: DMRC-34866997 Marketing Authorisation [...]

The post MHRA Class 4 Medicines Defect Notification: Olmesartan medoxomil 10mg film-coated tablets (Jubilant Pharmaceuticals NV) appeared first on Community Pharmacy England.